Document p2pKVYGd73XNn4X7QKOBZ1EDw

To: From: Cc: Bcc: Received Date: Subject: Brian Doll (E-mail)<brian.e.doll@exxonmobiLcom>; Burnett, Don (E-mail)<burnetdm@bp.com>; 'Michael Johnston' <Mike.d.Johnston@ConocoPhillips.com>; Zach Wong (E-mail)<ZachWong@chevrontexaco.com>; Bruce M. Jarnot (E-mail) <jarnotb@api.org>; Christopher Roythorne (E-mail) <chris.roythorne@uk.bp.com>; Jennifer Galvin (E-mail) <jennifer.b.galvin@conocophillips.com>; Michael Bird (E-mail) <michael.g.bird@exxonmobiLcom>; Russell White (E-mail)<russellwhite@chevrontexaco.com>; Tsai, Shan P SHLOIL-SHS <Shan.Tsai@shell.com>; Stephen Bowes (E-mail) <stephen.m.bowes@exxonmobiLcom>; Cagen, Stuart Z SCC-CF-SS <stuart.cagen@sheILcom>; Colletti, Sarah J SCC-CSEA <sarah.colietti@sheILcom>; Lynn Russo (E-mail) <lynn.b.russo@exxonmobiLcom>; Matthew Todd (E-mail) doddm@api.org>; Myron Harrison (E-mail) <myron.c.harrison@exxonmobil.com>; Richard Herold (E-mail) <heroldra@bp.com>; Valerie Crissey (E-mail) <vcrissey@chevrontexaco.com> Clegg, Patsy M SCC-CHSE-PC <lO=SHELLlOU=MSXSCC/CN=RECIPIENTS/CN=PH197432> Howard Feldman (E-mail) <feldmanh@api.org>; Bruce M. Jarnot (E-mail) <jarnotb@api.org>; Matthew Todd (E-mail) doddm@api.org>; 'Lorraine Twerdok' dwerdokl@api.org> 2005-06-2315:27:48 GMT FW: Shanghai Health Study Presentation to API HES GC didn't go through first time Regards, Patsy Patsy Clegg Product Steward, HSSE Shell Chem ical LP One Shell Plaza, 910 Louisiana, Houston, TX 77002-4916 Tel: +1 713241 2521 Fax: 3325 Email: patsy.clegg@shell.com Internet: http://www.shell.com/chemicals Business Success through HSSE Excellence -----Original Message----- From: Clegg, Patsy M SCC-CHSE-PC Sent: Thursday, June 23, 20057:29 AM To: Brian Doll (E-mail); Bumett, Don (E-mail); Michael Johnston; Zach Wong (E-mail); Bruce M. Jamot (E-mail); Christopher Roythome (E-mail); Jennifer Galvin (E-mail); Michael Bird (E-mail); Russell White (E-mail); Shan Tsai (E-mail); Stephen Bowes (E-mail); Stuart Cagen (E-mail); Colletti, Sarah J SCC-CSEA; Lynn Russo (E-mail); Matthew Todd (E-mail); Myron Harrison (E-mail); Richard Herold (E-mail); Valerie Crissey (E-mail) Cc: Howard Feldman (E-mail); Bruce M. Jarnot (E-mail); Matthew Todd (E-mail); Lorraine Twerdok Subject: Shanghai Health Study Presentation to API HES GC Team; SH ELL-MCCLU RG-064226 The SHS presentation to the API HES-GC went very well. The interest level was very high. There were a number of technical questions for which I did not know the answer, but Lorraine was there to very ably answer, thus rescuing me. The topic of the majority of questions was exposure. My response was that exposure is challenging, but that we are working hard to address those challenges. There were some questions as to the sustainability of the lab. I attach the slides that I used. Matt, would you add them to the web site? Thank you to those who contributed to reviewing the draft slide pack. Based on that review, I believe that we should revisit the current master slide set and revise based on what we have learned since the original ones were developed. Lynn, would you please take that action? Regards, Patsy HESGC sentation - June 20C Patsy Cle g Product Steward, HSSE Shell Chem ical LP One Shell Plaza, 910 Louisiana, Houston, TX 77002-4916 Tel: +1 713241 2521 Fax: 3325 Email: patsy.clegg@shell.com Internet: http://www.shell.com/chemicals Business Success through HSSE Excellence Attachments: HESGC Presentation - June 2005.ZIP SH ELL-MCCLU RG-064227